Best Life Sciences Companies in Haifa District, Israel

Ossio focuses on orthopedic fixation using bone regeneration technology. The company has developed OSSIOfiber, a biocomposite material platform that contains reinforcing synthetic bone fibers and bioabsorbable polymer resin. The fiber provides mechanical strength and the resin provides binding property and promotes bone growth.

Funding rounds

• Feb 2026Conventional Debt$50M
• Dec 2024Series C$27.6M
• Oct 2022Series C$38.5M
• Mar 2019Series A$22M

Founders & team

Orahn Preiss BloomFounder & PresidentBrian VerrierCEO

Investors

OCV Partners, Secocha Ventures, MVM, Questa Capital, Courage Capital Management, OrthoVision

Tech stack

Amazon SesAmazon Web ServicesCloudflareCloudflare Bot ManagementCore-JsGoogle Tag Manager

Developer of drugs for neurological disorders. It biologically-guided exosome therapy based on ExoTherapy platform technology for the treatment of acute spinal cord injury. It use exosomes as nanocarriers to deliver drug for neuron rewiring and regeneration.

Funding rounds

• Mar 2026Post IPO$279.9K
• Aug 2025Post IPO$147.8K
• Apr 2025Post IPO$1.6M
• Jan 2025Post IPO$434.5K

Founders & team

Lior ShaltielChief Executive Officer

Tech stack

CookieyesCore-JsDraftpress HfcmElementorGoogle Font ApiGoogle Tag Manager

AI-based oncology therapy plan solution for patients and professionals. The company has developed a proprietary proteomic analysis that can analyze the proteomic changes in the blood sample induced by the patient in response to cancer therapy. The company also provide treatment strategy to improve the effectiveness of therapy. It also provides consultancy services to patients, oncologists, nurses, and pharma companies among others. The company has developed PROphet which is a bioinformatics tool used to identify proteomic patterns related to therapy.

Funding rounds

• May 2025Grant (prize money)$2.8M
• May 2022Series C$35M
• Jan 2021Series B$8M
• Jan 2020Grant (prize money)—

Founders & team

Yuval ShakedCo-FounderOfer SharonCo-FounderOfer SharonCo-Founder & CEO

Investors

ALIVE, Leumi Partners, Menorah Mivathim, OurCrowd, BIRD Foundation, European Innovation Council

Tech stack

Cart FunctionalityCloudflareGoogle AnalyticsHstsHttp/3Jquery

Provider of MR-interfaced ultrasound technology-based device for cancer and neurology. The company's Exablate Neuro platform focuses on sound waves and guided by MRI to patients with medication-refractory essential tremor, Parkinson's Disease, uterine fibroids, and pain palliation of metastatic bone.

Funding rounds

• Jun 2024Series G$150M
• Sep 2022Conventional Debt—
• Nov 2020Series F—
• Mar 2020Series F$150M

Founders & team

Oded TamirCo-Founder & COOMaurice FerreChairman & CEOKobi VortmanPresident & Ceo

Investors

Koch Disruptive Technologies, Elbit Imaging, GE Equity, MediTech Advisors, Perceptive Advisors, The Community Fund

Tech stack

Adobe Audience ManagerApple Icloud MailCdnjsCloudflareCloudflare Bot ManagementCookiebot

Discovering immune system-based drugs by biological data analytics. It is using its proprietary platform of scientific and experimental data to stimulate the immune system so as to analyze its exponential growth in high-resolution patient data and in scientific research.

Funding rounds

• Jul 2024Conventional Debt—
• Jul 2024Series C$80M
• Sep 2022Series B$20M

Founders & team

David HarelCo-Founder and CEOElina StarosvetskyVp Scientific Alliances And Co-Founder

Investors

OurCrowd, Nvidia, Pfizer, Thermo Fisher Scientific, Bank Hapoalim, RM Venture Partners

Tech stack

Apache Http ServerApple Icloud MailCore-JsElementorGoogle AnalyticsHello Elementor

Minovia provides cell therapy treatment for mitochondrial disease. The company uses Mitochondria Augmentation Therapy (MAT) a proprietary method of isolating mitochondria from white blood cells or placentas. The placental blood of women is used to extract mitochondria, then the cell collection is done, and after that apheresis where doctors can select hematopoietic stem cells from the white blood cells collected and then, over 24 hours, introduce the healthy mitochondria to the stem cells.

Funding rounds

• Aug 2025Grant (prize money)$350K
• Oct 2022Grant (prize money)$266.1K

Founders & team

Natalie Yivgi-OhanaCEO

Investors

Europa, Countdownforacure, EIT Health, aMoon, Yozma

Tech stack

AddtoanyAddtoany Share ButtonsContact Form 7CookieyesCore-JsGodaddy

MeMed Diagnostics provides machine learning-based diagnostic solutions for infectious diseases. The company's lead product ImmunoXpert, distinguishes between bacterial and viral infections based on the patient’s immune response in-vitro diagnostic test. The company also offers ImmunoPoC, a device for distinguishing between bacterial and viral infections at the point-of-care. The company also provides its immunoassay platform MeMed Key. Its solution also diagnoses infections inaccessible for direct pathogen sampling and avoids false alarms due to the presence of non-pathogenic bacteria and viruses.

Funding rounds

• Jan 2022Series D$93M
• Jan 2020Grant (prize money)$2.8M
• Nov 2019Grant (prize money)$2.8M
• Nov 2018Grant (prize money)$3.3M

Founders & team

Eran EdenCo-Founder & CEO

Investors

EIC Fund, CDMRP, Europa, European Union, Foxconn Electronics, Horizons Ventures

Tech stack

All In One SeoAnime.JsCloudflareCloudflare Bot ManagementCore-JsDivi

V-Wave develops percutaneous implantable devices for treating patients with chronic Heart Failure. The compnay offers products like human implantable an inter-atrial shunt aimed at relieving symptoms and treating heart failure by controlling the left atrial pressure. The product is FDA approved.

Motus-GI's first product the Pure-Vu, is designed to clean a poorly prepped colon during a colonoscopy procedure, which may reduce the dependency on a successful pre-procedural prep regimen to gain clear visualization of the colon mucosa. The system consists of a disposable single-use over-sleeve and a workstation controller. The disposable over-sleeve fits easily over standard colonoscopes and is connected to the workstation. Pure-Vu does not interfere with the working channel or the navigation or advancement of the colonoscope. The workstation controls a novel irrigation technology that creates a pulsed mixture of water and air through 4 jets to loosen fecal material and an efficient evacuation cycle that effectively removes considerable colon content. It also has an auto-purge technology to prevent clogging.

Funding rounds

• May 2023Post IPO—
• Feb 2017Series A$30M
• Nov 2016Seed$82.5K

Founders & team

Timothy MoranChief Executive Officer

Investors

Perceptive Advisors, Orchestra Medical Ventures, Ascent Biomedical Ventures, Jacobs Investments, Pura Vida Investments, SRG

Tech stack

Apache Http ServerUnpkgScrollrevealJqueryGoogle Hosted LibrariesFont Awesome

Magentiq Eye provides software based on computer vision and machine learning technology to provide assistance to doctors in performing medical procedures. Its current portfolio includes software that assist in detection of colon cancer through colonoscopy and endoscopy.

BrainsGate is developing a platform technology for electrical stimulation of the sphenopalatine ganglion (SPG), a nervous center known to increase cerebral blood flow. Focus application is acute ischemic stroke. Has developed an implantable electrode which can be activated through an external system temporarily attached to the patient's cheek.

AI-powered insight platform to detect abnormalities in drug discovery. The platform empowers scientist and biotech firm, making AI-powered insights and to discover, develop and scale processes from alt-protein foods to new biopharmaceuticals.